Edgewise Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.About EWTX
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
CEOKevin Koch
CEOKevin Koch
Employees110
Employees110
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2017
Founded2017
Employees110
Employees110
EWTX Key Statistics
Market cap1.81B
Market cap1.81B
Price-Earnings ratio-11.14
Price-Earnings ratio-11.14
Dividend yield—
Dividend yield—
Average volume943.27K
Average volume943.27K
High today$17.52
High today$17.52
Low today$16.82
Low today$16.82
Open price$17.35
Open price$17.35
Volume558.84K
Volume558.84K
52 Week high$38.12
52 Week high$38.12
52 Week low$10.60
52 Week low$10.60
Stock Snapshot
As of today, Edgewise Therapeutics(EWTX) shares are valued at $17.18. The company's market cap stands at 1.81B, with a P/E ratio of -11.14.
On 2025-11-05, Edgewise Therapeutics(EWTX) stock traded between a low of $16.82 and a high of $17.52. Shares are currently priced at $17.18, which is +2.1% above the low and -1.9% below the high.
Edgewise Therapeutics(EWTX) shares are trading with a volume of 558.84K, against a daily average of 943.27K.
In the last year, Edgewise Therapeutics(EWTX) shares hit a 52-week high of $38.12 and a 52-week low of $10.60.
In the last year, Edgewise Therapeutics(EWTX) shares hit a 52-week high of $38.12 and a 52-week low of $10.60.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
23.1%
Sell
0%
People also own
Based on the portfolios of people who own EWTX. This list is generated using Robinhood data, and it’s not a recommendation.